A carregar...
Atherogenic Dyslipidemia and Combination Pharmacotherapy in Diabetes: Recent Clinical Trials
Patients with type 2 diabetes (T2D) are at a markedly increased risk of cardiovascular disease (CVD). Dyslipidemia is a common risk factor and a strong predictor of CVD in T2D patients. Although statins decrease the incidence of CVD in T2D, residual cardiovascular risk remains high despite the achie...
Na minha lista:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SBDR - Society for Biomedical Diabetes Research
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4063096/ https://ncbi.nlm.nih.gov/pubmed/24380092 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1900/RDS.2013.10.191 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|